Assessing depression symptoms in those with insomnia: An examination of the beck depression inventory second edition (BDI-II)
Introduction
MDD and PI share daytime symptoms (e.g., concentration difficulties, reduced sleep, and fatigue) (Moul et al., 2002), and insomnia is a highly prevalent complaint in those with MDD (Kupfer et al., 1982). Approximately 60% of adults meeting criteria for MDD complain of insomnia, and between 10% and 20% of adults endorsing current insomnia display evidence of MDD (Ohayon, 2007). Furthermore, self-report measures employed to assess depression include symptoms that are essential features of PI. For example, The BDI-II (Beck et al., 1996), includes the following symptoms that overlap with the Research Diagnostic Criteria (RDC) for insomnia (Edinger et al., 2004): insomnia, mood disturbance, irritability, fatigue, impaired concentration, and motivation/anergia. These symptoms have been reported in clinical studies of insomnia patients, and thus, informed development of RDC for insomnia.
Due to concerns about overlapping symptomatology between medical conditions and depression, the validity of the BDI and the BDI-II has been assessed in various medical populations. The BDI-II has been assessed in: chronic pain patients (Poole et al., 2006); Hepatitis C patients (Golden et al., 2007); adults post-acute coronary events (Di Benedetto et al., 2006); African American primary care patients (Dutton et al., 2004); traumatic brain injury patients (Rowland et al., 2005); low income African American medical patients (Grothe et al., 2005); medical outpatients (Viljoen et al., 2003); stroke patients (Aben et al., 2002); and in primary care medical patients (Arnau et al., 2001). The findings of these studies generally support the use of the BDI-II in these populations. However, Golden et al. (2007) found the BDI-II does not correspond well to a clinical diagnosis of MDD in Hepatitis C patients. The Cardiac Depression Scale was found to be more sensitive to the more subtle manifestation of depression than was the BDI-II in patients who are post-acute coronary syndrome (Di Benedetto et al., 2006), and Poole et al. (2006) suggest scoring the BDI-II using a two-factor approach in chronic pain patients. In summary, the empirical literature available thus far suggests support for the use of the BDI-II with most but not all medical populations.
As noted above, the assessment of depression in insomnia patients is similarly confounded by overlapping symptomatology across depressive and insomnia syndromes. As a result, it is difficult to ascertain whether elevated total scores or elevated responses on individual items of commonly used depression inventories reflect insomnia, depression with sleep symptoms, or comorbid insomnia and MDD. The purpose of this study was to assess the accuracy of the BDI-II, one of the most commonly used depression measures, in detecting MDD in patients known to meet diagnostic criteria for insomnia. To date, the BDI has not been evaluated for use with insomnia patients.
Section snippets
Participants
Participants were a mixture of clinic-referred patients who presented as outpatients seeking insomnia treatment or as research volunteers for ongoing insomnia treatment trials at two academic medical centers (Duke University Medical Center, Durham, NC and Rush Medical Center, Chicago, IL). Each site has an active insomnia clinic that services outpatients per calendar year as well as active NIH and/or industry sponsored insomnia research programs. The clinical patients at these sites include a
Results
The internal consistency estimate (i.e., Cronbach’s alpha) for the depressed and nondepressed groups were .888 and .817, respectively. Cronbach’s alpha was calculated using all 21 items.
Discussion
The purpose of this study was to examine the properties of the BDI-II in a group characterized by significant symptom overlap with depression (i.e., insomnia patients). As expected, those with insomnia and depression had higher scores on the summed score of the BDI-II than those with insomnia alone. It is of note however that the insomnia group with no depression had scores in the “mild” symptom range for the BDI-II, rather than the no-symptom range (i.e., scores below 14). The accuracy
Role of funding source
The funding sources for the data presented in this manuscript had no involvement in study design, collection, analysis and interpretation of data, writing of this manuscript, or the decision to submit it for publication.
Contributors
Jack Edinger, Colleen Carney and Andy Krystal designed and implemented the two studies from which data were collected for use in this study. Dr. Carney conducted the statistical analyses, prepared the first draft of the manuscript, and revised sections and conducted analyses for the second draft. Dr. Ulmer worked on the first draft, and revised sections and conducted analyses for the second draft. Dr. Edinger provided final edits of the first and second drafts, and wrote much of the Discussion
Conflict of interest statement
None of the authors have any financial, personal or other relationships with any entities who might inappropriately influence, or be perceived to have influenced the research presented in this manuscript.
Acknowledgements
This research was supported by a Pickwick Fellowship Award (Dr. Carney) from the National Sleep Foundation and by the National Institute of Mental Health Grant No. R01, MH067057 (Dr. Edinger).
References (41)
- et al.
Validity of the beck depression inventory, hospital anxiety and depression scale, SCL-90 and hamilton depression rating scale as screening instruments for depression in stroke patients
Psychosomatics: Journal of Consultation Liaison Psychiatry
(2002) Mood disorders
- et al.
Pretreatment REM sleep and subjective sleep quality distinguish depressed psychotherapy remitters and nonremitters
Biological Psychiatry
(1999) - et al.
Beliefs about sleep in disorders characterized by sleep and mood disturbance
Journal of Psychosomatic Research
(2007) - et al.
Depression following acute coronary syndromes: a comparison between the cardiac depression scale and the beck depression inventory II
Journal of Psychosomatic Research
(2006) - et al.
Use of the beck depression inventory-II with african american primary care patients
General Hospital Psychiatry
(2004) - et al.
Eszopiclone co-administered with fluoxetine in patients with insomnia co-existing with major depressive disorder
Biological Psychiatry
(2006) - et al.
Mini mental state: a practical method for grading the cognitive state of patients for the clinician
Journal of Psychiatric Research
(1975) - et al.
Reliability and validity of the hospital anxiety and depression scale and the beck depression inventory (full and fastscreen scales) in detecting depression in persons with Hepatitis C
Journal of Affective Disorders
(2007) - et al.
EEG sleep, depression and aging
Insomnia: a ticking clock for depression?
Journal of Psychiatric Research
Self-reported sleep disturbance as a prodromal symptom in recurrent depression
Journal of Affective Disorders
Sleep, depression, and suicide
Psychiatry Research
Sleep disturbances and suicidal behavior in patients with major depression
Journal of Clinical Psychiatry
EEG arousals: Scoring rules and examples
Sleep
Psychometric evaluation of the beck depression inventory-II with primary care medical patients
Health Psychology
Manual for the beck depression inventory (BDI-II)
Prevalence of DSM-III-R and ICD-10 psychiatric disorders in a spanish population of 18 year olds
Acta Psychiatrica Scandinavica
A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive behavioral therapy for major depression
The Journal of Clinical Psychiatry
Cited by (80)
Partner Alliance to Enhance Efficacy and Adherence of CBT-I
2023, Sleep Medicine ClinicsAssessing the causal associations of insomnia with depressive symptoms and subjective well-being: a bidirectional Mendelian randomization study
2021, Sleep MedicineCitation Excerpt :But insomnia can also be seen as an independent disease or risk factor which has complex interactions and associations with depressive symptoms and subjective well-being [12–14]. First, there is some overlap between symptoms of insomnia and depressive symptoms, such as fatigue and concentration problems [15,16]. Second, insomnia has the potential to worsen depressive symptoms and increase the risk of MDD [17,18].
- 1
Tel.: +1 416 979 5000x2177.